Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
12.06Prev. Close
12.13Volume
37,09,366Total traded value
4.90 CrUpper Circuit
15.84Lower Circuit
10.56Fundamentals
| Market Cap | ₹276Cr |
| ROE | 8.64% |
| P/E Ratio(TTM) | 14.98 |
| EPS(TTM) | 0.81 |
| P/B Ratio | 1.52 |
| Dividend Yield | 0.00% |
| Industry P/E | 35.07 |
| Book Value | 7.96 |
| Debt to Equity | 0.15 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Gennex Laboratories
Gennex Laboratories is engaged in manufacturing Bulk Drugs and Intermediates for domestic and international markets. The company is committed to sound corporate governance practices to ensure transparency and maximize shareholder value. Reflecting its strong growth, the company's net profit recorded an impressive increment of 160% during the year.;
| Parent Organisation | Gennex Laboratories Limited |
| Managing Director | Shri. Arihant Baid |
| BSE Symbol | 531739 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Jul '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 75.45 | ||
| Neuland Laboratories | NA (0.00%) | 118.92 | ||
| Jubilant Pharmova | NA (0.00%) | 38.23 | ||
| Acutaas Chemicals | NA (0.00%) | 64.32 |